DENTSPLY SIRONA Inc. (XRAY) Stock Analysis

Why this analysis is different

• A sector-relative MoonshotScore — five pillars (business quality, financial safety, valuation, growth durability, momentum) re-ranked nightly against the full universe of US-listed common stocks.
• An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
• Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

DENTSPLY SIRONA Inc. (XRAY) Healthcare & Pipeline Overview

DENTSPLY SIRONA Inc. (XRAY) provides a wide array of dental products and technologies, including treatment centers, CAD/CAM systems, and consumables, to dental professionals globally. With a history dating back to 1877, the company operates through two segments, focusing on both equipment and consumable dental products.

What Is the Investment Thesis for XRAY?

DENTSPLY SIRONA Inc. presents a mixed investment thesis. The company's established position in the dental products and technologies market, coupled with a dividend yield of 5.82%, may attract income-focused investors. However, a negative profit margin of -17.1% raises concerns about profitability. Growth catalysts include expanding its CAD/CAM technologies and clear aligner solutions. The company's beta of 1.00 indicates market correlation. Investors should closely monitor the company's ability to improve profitability and capitalize on growth opportunities in the dental market. The current market capitalization is $2.08B.

Based on FMP financials and quantitative analysis

XRAY Key Highlights

Market Cap of $2.08B reflects its current valuation in the dental products market.

• Gross Margin of 48.9% indicates the profitability of its products before operating expenses.
• Negative Profit Margin of -17.1% signals challenges in achieving overall profitability.
• Dividend Yield of 5.82% offers a substantial income stream to investors.
• Beta of 1.00 suggests the stock's price movements are correlated with the overall market.

Who Are XRAY's Competitors?

XRAY is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance This table mixes two scoring engines — compare a number only with others carrying the same tag.

What Are XRAY's Key Strengths?

Comprehensive product portfolio covering dental equipment and consumables.

• Established brand reputation and global presence.
• Technological expertise in digital dentistry.
• High dividend yield.

What Are XRAY's Weaknesses?

Negative profit margin.

• Exposure to competition from other dental product manufacturers.
• Dependence on dental professionals' adoption of new technologies.
• Potential impact from economic downturns on dental spending.

What Could Drive XRAY Stock Higher?

Launch of new CAD/CAM systems with enhanced capabilities to drive adoption among dental professionals.

• Expansion of clear aligner solutions (SureSmile) into new markets to increase market share.
• Strategic partnerships with dental clinics and universities to promote the use of DENTSPLY SIRONA products.
• Introduction of innovative dental consumables with improved performance and efficiency.

What Are the Key Risks for XRAY?

Financial-distress signal — its Altman Z-Score of 0.62 sits in the distress zone (elevated bankruptcy risk).

• Negative return on equity (-39.8%) — the business is not currently generating profit on shareholder capital.
• Intense competition from established and emerging players in the dental market.
• Changes in dental regulations and reimbursement policies affecting product sales.
• Product liability claims related to dental implants or other products.
• Economic downturns affecting dental spending and demand for elective procedures.
• Negative profit margin impacting financial stability and growth prospects.

What Are the Growth Opportunities for XRAY?

• Expansion of CAD/CAM Technologies: DENTSPLY SIRONA can drive growth by further expanding its CAD/CAM technologies for dental offices. The market for digital dentistry is growing, with increasing adoption of CAD/CAM systems for dental restorations and other procedures. By innovating and offering advanced CAD/CAM solutions, DENTSPLY SIRONA can capture a larger share of this market. The timeline for realizing this growth is ongoing, as dental practices continue to integrate digital technologies into their workflows.
• Growth in Clear Aligner Solutions: The market for clear aligner solutions is expanding, driven by increasing demand for discreet orthodontic treatments. DENTSPLY SIRONA offers both dentist-directed (SureSmile) and direct-to-consumer clear aligner solutions. By investing in marketing and expanding the availability of these solutions, DENTSPLY SIRONA can attract more customers and drive revenue growth. This growth opportunity is expected to materialize over the next several years.
• Penetration of Emerging Markets: Emerging markets offer significant growth opportunities for DENTSPLY SIRONA. As disposable incomes rise and awareness of oral health increases in these markets, demand for dental products and technologies is expected to grow. By establishing a strong presence in emerging markets and tailoring its product offerings to local needs, DENTSPLY SIRONA can tap into this growth potential. This is an ongoing opportunity as these markets continue to develop.
• Development of Innovative Consumables: DENTSPLY SIRONA can drive growth by developing and launching innovative dental consumables. The market for dental consumables is large and diverse, encompassing endodontic products, restorative materials, and small equipment. By investing in research and development and introducing new and improved consumables, DENTSPLY SIRONA can attract more customers and increase sales. This is an ongoing opportunity, as dental professionals constantly seek better and more efficient consumables.
• Strategic Acquisitions: DENTSPLY SIRONA can pursue strategic acquisitions to expand its product portfolio and market reach. By acquiring companies with complementary products or technologies, DENTSPLY SIRONA can strengthen its competitive position and accelerate growth. Potential acquisition targets could include companies specializing in niche dental products or emerging dental technologies. The timeline for acquisitions is variable, depending on market conditions and available opportunities.

What Are XRAY's Competitive Advantages?

• Established brand reputation in the dental industry.
• Comprehensive product portfolio covering a wide range of dental needs.
• Global distribution network reaching dental professionals worldwide.
• Technological expertise in digital dentistry and CAD/CAM systems.

What Does XRAY Do?

DENTSPLY SIRONA Inc., founded in 1877 and headquartered in Charlotte, North Carolina, is a global leader in the manufacturing and distribution of dental products and technologies. The company operates through two primary segments: Technologies & Equipment, and Consumables. The Technologies & Equipment segment offers a range of solutions including treatment centers, imaging equipment, motorized dental handpieces, and other instruments tailored for dental practitioners and specialists. This segment also provides advanced dental CAD/CAM technologies, supporting digital dental procedures such as dental restorations, dentist-directed clear aligner solutions (SureSmile), and direct-to-consumer clear aligner solutions, along with high-frequency vibration technology devices and implants. The Consumables segment focuses on products used in various dental procedures, including endodontic products like drills, filers, sealers, and irrigation needles for root canal treatments. It also offers restorative products such as artificial teeth, dental ceramics, digital dentures, precious metal dental alloys, and crown and bridge porcelain products. Additionally, the Consumables segment includes small equipment products like intraoral curing light systems, dental diagnostic systems, ultrasonic scalers and polishers, as well as dental anesthetics, prophylaxis paste, dental sealants, impression materials, teeth whiteners, and topical fluoride. DENTSPLY SIRONA serves the global dental market, providing comprehensive solutions for dental professionals worldwide.

What Products and Services Does XRAY Offer?

• Manufactures and sells dental treatment centers and imaging equipment.
• Provides CAD/CAM technologies for digital dental procedures.
• Offers dentist-directed and direct-to-consumer clear aligner solutions.
• Produces endodontic products for root canal procedures.
• Supplies restorative products like artificial teeth and dental ceramics.
• Offers small equipment such as intraoral curing lights and ultrasonic scalers.
• Provides dental anesthetics, sealants, and teeth whiteners.

How Does XRAY Make Money?

• Sells dental equipment and technologies to dental practitioners and specialists.
• Generates revenue from the sale of consumable dental products.
• Offers digital dentistry solutions, including CAD/CAM systems and clear aligners.
• Provides after-sales service and support for its equipment and technologies.

What Industry Does XRAY Operate In?

DENTSPLY SIRONA Inc. operates in the global dental market, which is characterized by increasing demand for advanced dental technologies and cosmetic dentistry. The market includes established players and innovative startups, creating a competitive landscape. Trends include the adoption of digital dentistry, CAD/CAM systems, and clear aligner solutions. DENTSPLY SIRONA is positioned to capitalize on these trends with its comprehensive product portfolio, but faces competition from companies offering similar solutions. The dental market is expected to grow due to increasing awareness of oral health and rising disposable incomes in emerging markets.

Who Are XRAY's Key Customers?

• Dental practitioners and specialists.
• Dental laboratories.
• Hospitals and clinics.
• Direct-to-consumer clear aligner customers.

Company Profile

DENTSPLY SIRONA Inc. operates in the Medical - Instruments & Supplies industry within the Healthcare sector. It is headquartered in Charlotte, US. The company is led by CEO Daniel T. Scavilla. XRAY has traded publicly since 1987.

DENTSPLY SIRONA Inc. Financial Trajectory

DENTSPLY SIRONA Inc. (XRAY) reported $898.0M in revenue for Q2 FY2026, reflecting 2.0% growth compared to the prior quarter. The company recorded net income of $37.0M, with diluted EPS of $0.18. Quarter-over-quarter revenue has been mixed, typical for a mid-cap company operating in Healthcare. Across the four most recent quarters, XRAY averaged $-0.68 in diluted EPS.

How DENTSPLY SIRONA Inc. Is Valued

DENTSPLY SIRONA Inc. carries a market capitalization of $2.08B, placing it in the mid-cap category. Analyst price targets span from $11.00 to $17.00, with a consensus of $14.00. At the current price of $10.37, that implies approximately 35% upside potential. Relative to its peer group, XRAY's quantitative score of 28/100 is below the peer average of 66/100.

Return on equity for DENTSPLY SIRONA Inc. stands at -39.8%, a gauge of how efficiently it converts shareholder capital into profit. Return on assets is -10.5%, showing how much profit it generates from its asset base. Its free cash flow yield is 6.8%, a gauge of the cash the business throws off relative to its market value. A current ratio of 1.63 indicates the company holds enough short-term assets to cover its near-term obligations. Its earnings yield is -25.9%, the inverse of the P/E and a quick read on earnings relative to price.

DENTSPLY SIRONA Inc.'s Piotroski F-Score is 5/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile. Its Altman Z-Score of 0.62 places it in the distress zone, a signal of elevated financial risk.

DENTSPLY SIRONA Inc. has beaten Wall Street's EPS estimate in 4 of its last 8 reported quarters — more hits than misses. Reported results have landed about 4.5% above estimates on average.

Over the past six months, DENTSPLY SIRONA Inc. insiders filed 30 SEC Form 4 transactions — 4 sales and 26 purchases. On net that is roughly 493K shares acquired (about $2.1M) — insiders putting money in tends to read as conviction.

XRAY Financials

XRAY Latest News

XRAY Analyst Consensus

XRAY MoonshotScore

Common Questions About XRAY (Healthcare)

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources